• SENSEX 76,391.39
    -363.66 (--0.47%)
  • BANKNIFTY 56,592.00
    -534.80 (--0.94%)
  • HDFC Bank
    743.25 726.75(%)
  • CIE Automotive
    411.35 382.20(%)
  • Oracle Fin.Serv.
    9,950.00 6,232.20(%)
  • Bluestone Jewel
    732.05 400.40(%)
  • Bharti Airtel
    1,925.60 1,745.00(%)
  • Reliance Industries
    1,268.00 1,253.65(%)
  • Bajaj Finance
    1,037.00 788.40(%)
  • Bajaj Finserv
    1,900.15 2,194.65(%)
  • Tanla Platforms
    656.70 765.75(%)
  • Maruti Suzuki
    13,371.65 12,202.10(%)
  • Gandhar Oil Ref.
    283.85 283.85(%)
  • Route Mobile
    649.90 945.00(%)
  • Eternal
    296.15 368.40(%)
  • Adani Green
    1,372.70 767.00(%)
  • Infosys
    1,032.30 984.00(%)
  • IndusInd Bank
    999.00 710.85(%)
  • SBI
    1,006.50 786.55(%)
  • Axis Bank
    1,219.05 1,041.30(%)
  • CG Power & Ind
    881.00 525.50(%)
  • SBI Funds Mgt.
    575.35 575.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Themis Medicare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Themis
  • BSE Code : 4895.0
  • ISIN : INE083B01024
107.79 0 (-0.41%)
  • As on 23 Jul 2026 (EOD)
  • Today’s Low

    106.64
  • Today’s High

    109.18
  • Open

    108.83
  • Perv Close

    108.23
  • 52W Low

    64.95
  • 52W High

    148.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    992.75

  • Div & Yield %

    0.46

  • Book Value(₹)

    29.10

  • Debt-Equity Ratio

    -0.41

  • AGM Date

    23-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    992.75

  • RONW (%)

    13.39

  • ROCE (%)

    14.99

Score Board

  • Equity (₹ in Cr.)

    9.21

  • BV (₹)

    29.10

  • Sales( ₹ in Cr.)

    342.24

  • NP (in Cr.)

    -13.37

  • NP Var(%)

    -156.0

  • Div%

    50.0

  • CPS (₹)

    -0.30

  • EPS (₹)

    -1.50

  • Traded Value (₹ in Lakhs)

    994.22

  • 52 Week High

    148.00

  • 52 Week Low

    64.95

  • Price BSE

    108.0

  • Price NSE

    108.00

  • Market Capital( in Cr.)

    994.22

  • P/C Ratio

    -326.20

  • P/E Ratio

    -74.40

  • Price Vs.BV

    -1.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 405.51 381.76 354.32 394.61 230.67 201.59
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 405.51 381.76 354.32 394.61 230.67 201.59
Other Income 4.67 4.76 11.50 6.54 3.62 3.47
Stock Adjustments 17.98 1.57 7.79 -3.06 1.27 3.49
Total Income 428.16 388.09 373.61 398.09 235.56 208.55
EXPENDITURE :            
Raw Materials 149.98 138.28 126.16 145.08 79.48 66.67
Power and Fuel Cost 11.81 13.46 11.83 12.18 11.32 11.49
Employee Cost 96.38 82.41 66.15 51.97 39.99 44.28
Other Manufacturing Expenses 29.02 27.52 25.98 32.96 16.11 16.93
Selling and Administration Expenses 60.77 51.84 44.15 34.85 21.00 22.17
Miscellaneous Expenses 26.48 18.29 20.39 18.86 14.16 7.86
Employee Benefit Expenses 96.38 82.41 66.15 51.97 39.99 44.28
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 374.44 331.79 294.66 295.90 182.06 169.39
Operating Profit 53.73 56.29 78.96 102.19 53.50 39.15
Interest 10.04 9.38 9.56 8.77 12.71 12.88
Gross Profit 43.69 46.91 69.40 93.42 40.79 26.27
Depreciation 9.93 12.25 10.49 9.48 8.55 8.27
Profit Before Tax 33.76 34.66 58.91 83.94 32.24 18.00
Current Tax 8.30 9.22 15.00 16.75 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.54 0.70 0.61 5.63 5.63 2.09
Reported Net Profit 23.92 24.75 43.29 61.56 26.62 15.91
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 23.92 24.75 43.29 61.56 26.62 15.91
Adjustment below Net Profit -0.31 -0.74 -0.43 -0.32 1.46 -0.17
P & L Balance brought forward 155.50 135.62 96.79 38.98 11.98 -4.27
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.20 4.14 4.03 3.43 1.09 -0.51
P & L Balance carried down 174.91 155.50 135.62 96.79 38.98 11.98
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 50.00 50.00 43.00 17.50
Dividend Per Share(Rs) 0.50 0.50 5.00 5.00 4.30 1.75
Earnings Per Share-Unit Curr 2.60 2.69 47.04 66.91 28.97 17.32
Earnings Per Share(Adj)-Unit Curr 2.60 2.69 4.70 6.69 2.90 1.73
Book Value 31.22 29.11 269.54 227.50 164.59 135.33
Book Value(Adj)-Unit Curr 31.22 29.11 26.96 22.75 16.46 13.53

Shareholding Pattern

  • Promoter Group

    67.11%

  • Public Share Holding

    32.89%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 8,843,080 9.60 8,843,080 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 8,843,080 9.60 8,843,080 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 24,429,460 26.52 24,429,460 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 28,531,450 30.98 28,531,450 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 52,960,910 57.50 52,960,910 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 10,000 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,801 0.01 8,801 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,135 0.00 1,135 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 450 0.00 450 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,386 0.02 10,386 7
2] Non Institution
Bodies Corporate 3,400,998 3.69 3,399,998 126
Clearing Members 92,130 0.10 92,130 16
Directors of their Relatives 72,500 0.08 72,500 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,835,111 3.08 2,659,111 309
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,609,328 1.75 1,608,188 616
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,916,099 6.42 5,916,099 9
Individuals holding nominal share capital up to Rs. 1 lakh 15,793,816 17.15 15,187,055 20,151
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 366,840 0.40 366,840 2
Sub Total 30,275,744 32.87 29,490,843 21,249
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 92,100,120 100.00 91,305,219 21,267

Company Background

Themis Medicare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Themis Medicare Ltd
  • BSE Code : 4895.0
  • ISIN : INE083B01024
  • Incorporation Year

    1969

  • Registered Office

    Plot No 69 A GIDC Indl Estate
    Vapi, Valsad,
    Gujarat-396195

  • Telephone

    91-260-2421675

  • FAX

    91-260-2430219

  • Chairman

    Dinesh S Patel

  • Managing Director

  • Company Secretary

  • Auditor

    Krishaan & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Themis Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Themis Medicare 107.95 410.18 405.51 -70.10 11.88
Abbott India 28,735.45 7,217.19 6,929.05 39.34 43.78
Astrazeneca Phar 7,873.60 2,304.07 2,275.58 104.97 27.86
P & G Health Ltd 6,703.25 944.52 934.17 34.04 71.75
Glaxosmi. Pharma 2,494.20 3,932.76 3,790.20 41.76 58.17
Cipla 1,393.75 20,102.60 18,979.95 32.03 13.88
Amrutanjan Healt 518.15 469.50 451.82 25.87 21.89
Bliss GVS Pharma 462.85 773.53 729.81 50.70 12.51
Fermenta Biotec. 401.95 474.15 450.25 18.40 18.77
Guj. Themis Bio. 355.30 152.47 150.80 83.01 27.21
Ambalal Sarabhai 32.67 19.52 3.94 22.85 6.77